Journal
TRANSPLANT INFECTIOUS DISEASE
Volume 11, Issue 4, Pages 290-297Publisher
WILEY
DOI: 10.1111/j.1399-3062.2009.00407.x
Keywords
mycophenolate mofetil; solid organ transplant; cytomegalovirus; BK virus
Categories
Funding
- National Institutes of Health [R01AI045459, R01AI035370]
Ask authors/readers for more resources
P>Mycophenolate mofetil (MMF) is one of the most frequently used immunosuppressive drugs in solid organ transplant recipients. MMF is an inhibitor of inosine-5'-monophosphate, and is able to preferentially inhibit B-cell and T-cell function. The immunosuppressive abilities of MMF have made it one of the most successful anti-rejection drugs in transplant patients, but patients also appear to have increased susceptibility to infections, specifically cytomegalovirus and BK virus. Despite its association with an increased risk of infection, MMF has also exhibited antimicrobial activity against pathogens including hepatitis C, Pneumocystis jirovecii, and human immunodeficiency virus. A thorough understanding of the functions of MMF on the immune system and interaction with infectious pathogens could be helpful in implementing preventative strategies against opportunistic infections in transplant patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available